«Serum betaine, N,N-dimethylglycine and N-methylglycine levels in patients with cobalamin and folate deficiency and related inborn errors of metabolism». Metabolism42 (11): 1448-60. November 1993. PMID7694037. doi:10.1016/0026-0495(93)90198-W.
Perry, Kenneth W.; Falcone, Julie F.; Fell, Matthew J.; Ryder, John W.; Yu, Hong; Love, Patrick L.; Katner, Jason; Gordon, Kimberly D. et al. (October 2008). «Neurochemical and behavioral profiling of the selective GlyT1 inhibitors ALX5407 and LY2365109 indicate a preferential action in caudal vs. cortical brain areas». Neuropharmacology55 (5): 743-754. PMID18602930. doi:10.1016/j.neuropharm.2008.06.016.Se sugiere usar |número-autores= (ayuda)
«Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia». Biological Psychiatry60 (6): 645-9. September 2006. PMID16780811. doi:10.1016/j.biopsych.2006.04.005.
«Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia». Biological Psychiatry55 (5): 452-6. March 2004. PMID15023571. doi:10.1016/j.biopsych.2003.09.012.
«Meta-analysis of the efficacy of adjunctive NMDA receptor modulators in chronic schizophrenia». CNS Drugs25 (10): 859-85. October 2011. PMID21936588. doi:10.2165/11586650-000000000-00000.
«Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours». European Urology58 (1): 12-8; discussion 20-1. July 2010. PMID20117878. doi:10.1016/j.eururo.2010.01.035.
«Serum sarcosine is not a marker for prostate cancer». Annals of Clinical Biochemistry47 (Pt 3): 282. May 2010. PMID20233752. doi:10.1258/acb.2010.009270.
«Serum betaine, N,N-dimethylglycine and N-methylglycine levels in patients with cobalamin and folate deficiency and related inborn errors of metabolism». Metabolism42 (11): 1448-60. November 1993. PMID7694037. doi:10.1016/0026-0495(93)90198-W.
Perry, Kenneth W.; Falcone, Julie F.; Fell, Matthew J.; Ryder, John W.; Yu, Hong; Love, Patrick L.; Katner, Jason; Gordon, Kimberly D. et al. (October 2008). «Neurochemical and behavioral profiling of the selective GlyT1 inhibitors ALX5407 and LY2365109 indicate a preferential action in caudal vs. cortical brain areas». Neuropharmacology55 (5): 743-754. PMID18602930. doi:10.1016/j.neuropharm.2008.06.016.Se sugiere usar |número-autores= (ayuda)
«Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia». Biological Psychiatry60 (6): 645-9. September 2006. PMID16780811. doi:10.1016/j.biopsych.2006.04.005.
«Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia». Biological Psychiatry55 (5): 452-6. March 2004. PMID15023571. doi:10.1016/j.biopsych.2003.09.012.
«Meta-analysis of the efficacy of adjunctive NMDA receptor modulators in chronic schizophrenia». CNS Drugs25 (10): 859-85. October 2011. PMID21936588. doi:10.2165/11586650-000000000-00000.
«Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours». European Urology58 (1): 12-8; discussion 20-1. July 2010. PMID20117878. doi:10.1016/j.eururo.2010.01.035.
«Serum sarcosine is not a marker for prostate cancer». Annals of Clinical Biochemistry47 (Pt 3): 282. May 2010. PMID20233752. doi:10.1258/acb.2010.009270.